Message Font: Serif | Sans-Serif
 
No. of Recommendations: 1
Looked back over my interview, and with a bit of embarrassment have to correct the guy's name. (Too much on my mind!) Scratch Misha Rosenbach. It's Mike Rosenblum, at UCSF. He had formed a partnership with a dermatology scientist who had developed an agent to balance the Treg population. Tested in a mouse model of lupus, tested in various human tissue cultures, and tested in nonhuman primates, it was amazing. They sold their company to Celgene. I just looked at their pipeline, and they do have a product in trials to treat systemic lupus, but I couldn't easily find information on it. So I don't know if that's the Treg balancer or not. Early clinical data included significant safety concerns. Don't have time to pursue it further right now. But will as soon as I can. And I'll see if I can learn anything from Mike Rosenblum.

=sheila
Print the post  

Announcements

What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.